News

Imperial College London's technology commercialisation company is betting on a spin-out company, deltaDOT, to speed detection and decrease costs of finding new proteins for drug discovery.

Partnerships: An EU project aims to design road-hardened microchips in a fast-changing market.

Energy: The Manchester “bobber” is using the power of ocean waves to find a lower-cost route to alternative energy.

Scientists love to complicate things; and if you're not in the same field, or – worse – are in business or investment, then it's easy to get lost. Enter the Science|Business Quick Guides to some of the hottest fields of science and technology…

Michael Kenward's roundup of new studies, reports and tools for the business of science

Barry Fox thinks that the patent system is deliberately designed to make it hard to find out anything.

By mixing academic research with commercial ventures, Sir Richard Friend has returned to the scientific traditions of Faraday and Kelvin. He has also created a new role model for the modern scientist.

How a Swiss university spin-off got to exit in six years - Interview with Joël Jean-Mairet, Chief Executive Officer and Joint Founder, GlycArt.

Acquisition gives Roche access to antibody-boosting technology - and possible anti-cancer treatments in the pipeline

Once upon a time, there were great businesses with massive central labs that did both product development and basic research. Today, most corporate labs have refocused on applied research. They do not know what they are missing.